[Correspondence] Recommendations based on value, not cost
Basing decisions to recommend new treatments, appraised by the National Institute for Health and Care Excellence (NICE), on value is undoubtedly correct. But what does value mean in this context? Clearly, to patients, value means the prospect of an improvement in their condition and, for terminally ill people with cancer, the potential for life to be extended. But for the UK’s National Health Service (NHS), value also means investment of scarce resources that can be justified in light of the health benefit they will confer.